Amneal Pharmaceuticals, Inc. (NASDAQ:AMRX) appears in 271 institutional 13F filings for the quarter ending December 2025.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| VANGUARD GROUP INC | 31 Dec, 2025 | 17,907,815 | -47,158 | -0.26% | $225,638,469.00 |
| BlackRock, Inc. | 31 Dec, 2025 | 14,298,520 | 224,867 | 1.60% | $180,161,353.00 |
| Rubric Capital Management LP | 31 Dec, 2025 | 12,334,941 | 0 | 0.00% | $155,420,257.00 |
| TPG GP A, LLC | 31 Dec, 2025 | 12,328,767 | 0 | 0.00% | $155,342,464.00 |
| CITADEL ADVISORS LLC | 31 Dec, 2025 | 6,175,737 | 446,438 | 7.79% | $77,814,286.00 |
| DIMENSIONAL FUND ADVISORS LP | 31 Dec, 2025 | 5,609,040 | 177,906 | 3.28% | $70,680,550.00 |
| Goldman Sachs Group Inc | 31 Dec, 2025 | 5,162,150 | 2,701,936 | 109.83% | $65,043,090.00 |
| Morgan Stanley | 31 Dec, 2025 | 4,818,099 | 1,315,018 | 37.54% | $60,708,057.00 |
| State Street Corp | 31 Dec, 2025 | 4,110,410 | 136,662 | 3.44% | $51,791,166.00 |
| GEODE CAPITAL MANAGEMENT, LLC | 31 Dec, 2025 | 3,986,554 | -48,079 | -1.19% | $50,239,137.00 |
| Assenagon Asset Management S.A. | 31 Dec, 2025 | 3,761,739 | 1,611,698 | 74.96% | $47,397,911.00 |
| Neuberger Berman Group LLC | 31 Dec, 2025 | 3,655,391 | -60,684 | -1.63% | $46,098,068.00 |
| MILLENNIUM MANAGEMENT LLC | 31 Dec, 2025 | 3,360,198 | 27,447 | 0.82% | $42,338,495.00 |
| Nuveen, LLC | 31 Dec, 2025 | 3,221,721 | -3,511 | -0.11% | $40,593,684.00 |
| D. E. Shaw & Co., Inc. | 31 Dec, 2025 | 2,661,854 | 1,096,643 | 70.06% | $33,539,360.00 |
| Phocas Financial Corp. | 31 Dec, 2025 | 2,565,948 | 1,280,164 | 99.56% | $32,330,944.00 |
| Nantahala Capital Management, LLC | 31 Dec, 2025 | 2,447,516 | -1,777,048 | -42.06% | $30,838,702.00 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 31 Dec, 2025 | 2,144,471 | 61,657 | 2.96% | $27,020,329.00 |
| ACADIAN ASSET MANAGEMENT LLC | 31 Dec, 2025 | 2,021,171 | -569,351 | -21.98% | $25,455.00 |
| Invesco Ltd. | 31 Dec, 2025 | 1,750,718 | 65,332 | 3.88% | $22,059,048.00 |